CVS Health Corporation (NYSE:CVS) Short Interest Update

CVS Health Corporation (NYSE:CVS) was the target of a large drop in short interest in the month of January. As of January 15th, there was short interest totaling 18,762,000 shares, a drop of 13.4% from the December 31st total of 21,665,261 shares. Based on an average trading volume of 7,566,253 shares, the short-interest ratio is presently 2.5 days. Approximately 1.5% of the shares of the company are short sold. Approximately 1.5% of the shares of the company are short sold. Based on an average trading volume of 7,566,253 shares, the short-interest ratio is presently 2.5 days.

Analyst Ratings Changes

CVS has been the subject of several recent analyst reports. Jefferies Financial Group upped their target price on shares of CVS Health from $92.00 to $98.00 in a research report on Thursday, October 30th. Cantor Fitzgerald restated an “overweight” rating on shares of CVS Health in a research report on Wednesday, December 10th. Barclays lifted their target price on CVS Health from $87.00 to $93.00 and gave the company an “overweight” rating in a research note on Wednesday, December 10th. Piper Sandler reissued an “overweight” rating and issued a $101.00 price target (up previously from $99.00) on shares of CVS Health in a research note on Wednesday, December 10th. Finally, Weiss Ratings restated a “hold (c-)” rating on shares of CVS Health in a research note on Monday, December 29th. Nineteen equities research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $94.82.

Institutional Trading of CVS Health

Several hedge funds and other institutional investors have recently modified their holdings of the business. Indivisible Partners purchased a new stake in CVS Health in the 4th quarter worth about $585,000. RFG Advisory LLC increased its holdings in CVS Health by 315.4% in the fourth quarter. RFG Advisory LLC now owns 21,998 shares of the pharmacy operator’s stock worth $1,746,000 after buying an additional 16,702 shares during the last quarter. Stevens Capital Management LP increased its stake in shares of CVS Health by 6.1% during the 4th quarter. Stevens Capital Management LP now owns 13,370 shares of the pharmacy operator’s stock worth $1,061,000 after purchasing an additional 773 shares during the last quarter. Swedbank AB lifted its position in shares of CVS Health by 1.1% in the fourth quarter. Swedbank AB now owns 2,272,773 shares of the pharmacy operator’s stock worth $180,367,000 after buying an additional 23,989 shares during the last quarter. Finally, Mitsubishi UFJ Asset Management Co. Ltd. raised its stake in shares of CVS Health by 5.7% in the 4th quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 2,662,759 shares of the pharmacy operator’s stock valued at $213,367,000 after acquiring an additional 144,166 shares in the last quarter. Institutional investors and hedge funds own 80.66% of the company’s stock.

CVS Health Price Performance

CVS Health stock traded up $1.27 during midday trading on Tuesday, hitting $76.69. The company’s stock had a trading volume of 988,497 shares, compared to its average volume of 9,897,570. CVS Health has a 12 month low of $53.36 and a 12 month high of $85.15. The company has a quick ratio of 0.63, a current ratio of 0.83 and a debt-to-equity ratio of 0.83. The stock’s 50-day moving average price is $78.85 and its 200-day moving average price is $75.33. The company has a market capitalization of $97.36 billion, a PE ratio of 202.11, a price-to-earnings-growth ratio of 0.69 and a beta of 0.50.

CVS Health Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Monday, February 2nd. Stockholders of record on Thursday, January 22nd were given a dividend of $0.665 per share. The ex-dividend date of this dividend was Thursday, January 22nd. This represents a $2.66 dividend on an annualized basis and a dividend yield of 3.5%. CVS Health’s payout ratio is 700.00%.

About CVS Health

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.